Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2531579017 | Agalsidase beta 5mg powder for injection solution vial (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2535111010 | Agalsidase beta 5mg powder for injection solution vial | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 2537890014 | Agalsidase beta 5mg i-v infusion (pdr for recon) vial | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3689388012 | Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3689389016 | Agalsidase beta 5 mg powder for solution for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3689390013 | Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Agalsidase beta 5 mg powder for solution for injection vial | Is a | Agalsidase beta only product in parenteral dose form | true | Inferred relationship | Some | ||
| Agalsidase beta 5 mg powder for solution for injection vial | Is a | Agalsidase beta-containing product | false | Inferred relationship | Some | ||
| Agalsidase beta 5 mg powder for solution for injection vial | Has active ingredient | Alpha-galactosidase | false | Inferred relationship | Some | ||
| Agalsidase beta 5 mg powder for solution for injection vial | Has active ingredient | Biological agent | false | Inferred relationship | Some | ||
| Agalsidase beta 5 mg powder for solution for injection vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Agalsidase beta 5 mg powder for solution for injection vial | Has active ingredient | Agalsidase beta | false | Inferred relationship | Some | ||
| Agalsidase beta 5 mg powder for solution for injection vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
| Agalsidase beta 5 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Agalsidase beta 5 mg powder for solution for injection vial | Has BoSS | Agalsidase beta | true | Inferred relationship | Some | 1 | |
| Agalsidase beta 5 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Agalsidase beta 5 mg powder for solution for injection vial | Has unit of presentation | Vial | true | Inferred relationship | Some | ||
| Agalsidase beta 5 mg powder for solution for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Agalsidase beta 5 mg powder for solution for injection vial | Has presentation strength numerator value | 5 | false | Inferred relationship | Some | 1 | |
| Agalsidase beta 5 mg powder for solution for injection vial | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Agalsidase beta 5 mg powder for solution for injection vial | Has precise active ingredient | Agalsidase beta | true | Inferred relationship | Some | 1 | |
| Agalsidase beta 5 mg powder for solution for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
REPLACED BY association reference set
FHIR